Ni/Photoredox-Catalyzed Enantioselective Cross-Electrophile Coupling of Styrene Oxides with Aryl Iodides
作者:Sii Hong Lau、Meredith A. Borden、Talia J. Steiman、Lucy S. Wang、Marvin Parasram、Abigail G. Doyle
DOI:10.1021/jacs.1c08105
日期:2021.9.29
computational mechanistic studies were conducted, lending support to the hypothesis that reductive elimination is enantiodetermining and the electronic character of the ligands influences the enantioselectivity by altering the position of the transition state structure along the reactioncoordinate. This study demonstrates the benefits of utilizing statistical modeling as a platform for mechanistic understanding
Visible-Light-Mediated Anti-Markovnikov Hydration of Olefins
作者:Xia Hu、Guoting Zhang、Faxiang Bu、Aiwen Lei
DOI:10.1021/acscatal.6b03388
日期:2017.2.3
avoided the need for a transition-metal catalyst, stoichiometric borane, as well as oxidant. Both terminal and internal olefins are readily accommodated in this transformation to obtain corresponding primary and secondary alcohols in good yields with single regioselectivity. This procedure can be scaled up to gram scale with a 230 turnover number based on photocatalyst.
PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES
申请人:PROLYNX LLC
公开号:US20140296476A1
公开(公告)日:2014-10-02
The present invention provides methods and compositions that permit controlled and prolonged drug release in vivo. The compounds are either prodrugs with tunable rates of release, or conjugates of the drug with macromolecules which exhibit tunable controlled rates of release.